Vivos (RDGL) Total Debt (2010 - 2023)

Vivos (RDGL) reported Total Debt of $10000.0 for Q3 2023, down 99.68% sequentially from $3.1 million in Q1 2019.

Vivos (RDGL) Total Debt (2010 - 2023) Analysis & Trends

Vivos (RDGL) has 11 years of Total Debt data on file, last reported at $10000.0 in Q3 2023.

For the quarter ending Q3 2023, Total Debt changed N/A year-over-year to $10000.0; the trailing twelve-month figure through Sep 2023 stood at $10000.0 (changed N/A YoY), and the FY2018 full-year result was $3.1 million, changed N/A from the prior year.
Total Debt fell to $10000.0 in Q3 2023, from $3.1 million in the prior quarter.
In the past five years, Total Debt ranged from a high of $3.1 million in Q1 2019 to a low of $10000.0 in Q3 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn	34.05 Bn
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn	14.72 Bn
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn	27.96 Bn
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn	11.03 Bn
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn	598.50 Mn
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn	-
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn	10.14 Bn
8	Smith & Nephew	26.99 Bn	26.41 Bn	-	3.18 Bn
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn	9.48 Bn
10	Vivos	27.16 Mn	25.60 Mn	-3,105.00	-

Historic Data

Download Data

Date	Value
Sep 30, 2023	10,000.00
Mar 31, 2019	3.14 Mn
Dec 31, 2018	3.14 Mn
Sep 30, 2018	32,279.00
Mar 31, 2018	40,000.00
Sep 30, 2017	383,771.00
Jun 30, 2017	383,771.00
Mar 31, 2017	383,771.00
Dec 31, 2016	332,195.00
Sep 30, 2016	332,195.00
Jun 30, 2016	332,195.00
Mar 31, 2016	1.33 Mn
Dec 31, 2015	1.28 Mn
Sep 30, 2015	1.06 Mn
Jun 30, 2015	4.53 Mn
Mar 31, 2015	935,806.00
Dec 31, 2014	4.46 Mn
Sep 30, 2014	512,094.00
Jun 30, 2014	583,429.00
Mar 31, 2014	349,913.00